![](http://www.alamy.com/thumbs/6/2334A145-2064-4B7D-B3CD-62A5013F9E82/PKHK93.jpg)
Alemtuzumab monoclonal antibody drug. Targets CD52. Used in treatment of leukemia and multiple sclerosis. Generic name and stylized antibody represent
Alemtuzumab monoclonal antibody drug. Targets CD52. Used in treatment of leukemia and multiple sclerosis. Generic name and stylized antibody representation.
Size: 6626px × 2508px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No
Keywords: alemtuzumab, antibody, biological, biosimilar, biotech, biotechnology, cd52, chronic, cll, disease, drug, graft, gvhd, host, humanized, immunoglobulin, immunology, infusion, injection, inn, leukemia, lymphocyte, lymphocytic, lymphoma, mab, monoclonal, ms, multiple, nomenclature, peptide, protein, sclerosis